TARGET-BASED METHOD FOR HIGH-THROUGHPUT AND SUBCLASS SPECIFIC IgG GLYCAN PROFILING IN HUMAN PLASMA
US-2024353417-A1 · Oct 24, 2024 · US
US9873746B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9873746-B2 |
| Application number | US-201113070583-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 24, 2011 |
| Priority date | Oct 22, 2003 |
| Publication date | Jan 23, 2018 |
| Grant date | Jan 23, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods are provided for the synthesis and secretion of recombinant proteins preferably large mammalian proteins or hetero-multimeric proteins at high levels and for prolonged time in polyploid, preferably diploid yeast. These methods use various mating competent yeast, including Pichia . In a preferred embodiment, a first expression vector is transformed into a first haploid cell; and a second expression vector is transformed into a second haploid cell. The transformed haploid cells, each individually synthesizing a non-identical polypeptide, are identified and then genetically crossed or fused. The resulting diploid strains are utilized to produce and secrete fully assembled and biologically functional hetero-multimeric protein.
Opening claim text (preview).
What is claimed is: 1. A diploid Pichia pastoris yeast culture which is cultured under conditions whereby the diploid Pichia pastoris yeast culture expresses and secretes into the culture medium a heterologous multichain polypeptide encoded by one or more heterologous DNAs operably linked to a promoter, wherein said one or more heterologous DNAs are expressed by diploid Pichia pastoris yeast cells comprised in said diploid Pichia yeast culture, wherein the heterologous multichain polypeptide is other than an antibody or antibody fragment that specifically binds to a target antigen, wherein the density of Pichia pastoris in the culture is at least 100 g/L. 2. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 200 g/L. 3. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 300 g/L. 4. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 400 g/L. 5. The diploid Pichia pastoris yeast culture of claim 1 wherein the density of Pichia pastoris in the culture is at least 500 g/L. 6. The diploid Pichia pastoris yeast culture of claim 1 wherein said one or more heterologous DNAs are comprised on a plasmid. 7. The diploid Pichia pastoris yeast culture of claim 1 wherein said one or more heterologous DNAs are integrated into the chromosomal DNA of said yeast. 8. The diploid Pichia pastoris yeast culture of claim 1 , wherein the heterologous polypeptide is selected from the group consisting of a hormone, growth factor, cytokine, lymphokine, enzyme, receptor, cytotoxin, lymphotoxin, immunotoxin, and a tumor polypeptide.
for yeasts · CPC title
against material from animals or humans · CPC title
against the T-cell receptor (TcR)-CD3 complex · CPC title
containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered · CPC title
Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.